Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibrutinib Maintenance in Elderly PCNSL
NCT02623010Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Oct 2016
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in primary central nervous system lymphoma (PCNSL), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
ibrutinib
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT02623010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623010.